<PAGE> 1
As filed with the Securities and Exchange Commission on July 24, 1997
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
For Registration of Certain Classes of Securities
Pursuant to Section 12(b) or 12(g) of the
Securities Exchange Act of 1934
BioReliance Corporation
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 52-1541583
- --------------------------------------------------------------------------------
(State of incorporation or organization) (I.R.S. Employer Identification No.)
9900 Blackwell Road, Rockville, Maryland 20850
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
If this Form relates to the registration of a class of debt securities and is
effective upon filing pursuant to General Instruction A.(c)(1), please check
the following box. [ ]
If this Form relates to the registration of a class of debt securities and is
to become effective simultaneously with the effectiveness of a concurrent
registration statement under the Securities Act of 1933 pursuant to General
Instruction A.(c)(2), please check the following box. [ ]
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange on
to be so registered which each class is to be registered
------------------- ------------------------------------
None
- --------------------------------------------------------------------------------
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, $.01 par value
- --------------------------------------------------------------------------------
(Title of class)
Total of 3 Pages
<PAGE> 2
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Item 1. Description of the Registrant's Securities to be Registered
The description of the Common Stock, $.01 par value, of
BioReliance Corporation (the "Registrant") to be registered hereunder is
contained under the caption "Description of Capital Stock" in the Prospectus
constituting a part of the Registration Statement on Form S-1 (No. 333-25071)
filed by the Registrant with the Commission on April 11, 1997, as amended,
which is incorporated herein by reference as Exhibit 1.
Item 2. Exhibits
Listed below are all exhibits filed as part of this
Registration Statement:
1. Registration Statement on Form S-1 (No. 333-25071) filed on
April 11, 1997, as amended (the "Registration Statement").*
2. Amended and Restated Certificate of Incorporation of
Registrant (Exhibit 3.1 to the Registration Statement).
3. Bylaws of Registrant (Exhibit 3.2 to the Registration
Statement).
4. Specimen certificate representing shares of Common Stock, $.01
par value of the Registrant (Exhibit 4.1 to the Registration
Statement).
- --------------------
* Incorporated herein by reference.
<PAGE> 3
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities
Exchange Act of 1934, the Registrant has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereto duly
authorized.
Date: July 24, 1997
BIORELIANCE CORPORATION
By: /s/ Capers W. McDonald
---------------------------
Capers W. McDonald
President and Chief Executive Officer
